These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 19556728

  • 1. Nifedipine interferes with migration of vascular smooth muscle cells via inhibition of Pyk2-Src axis.
    Soe NN, Ishida T, Ishida M, Sawano M, Abe K, Miho N, Chayama K, Kihara Y, Yoshizumi M.
    J Atheroscler Thromb; 2009 Jun; 16(3):230-8. PubMed ID: 19556728
    [Abstract] [Full Text] [Related]

  • 2. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Böhmer FD.
    Circ Res; 1999 Jul 09; 85(1):12-22. PubMed ID: 10400906
    [Abstract] [Full Text] [Related]

  • 3. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
    Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, Griendling KK.
    Circ Res; 2004 May 14; 94(9):1219-26. PubMed ID: 15059930
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
    Blaschke F, Stawowy P, Kappert K, Goetze S, Kintscher U, Wollert-Wulf B, Fleck E, Graf K.
    Basic Res Cardiol; 2002 Jul 14; 97(4):334-42. PubMed ID: 12111044
    [Abstract] [Full Text] [Related]

  • 5. PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca2+ channels with full-length CaV1.2 C-terminus.
    Guo X, Kashihara T, Nakada T, Aoyama T, Yamada M.
    Pflugers Arch; 2018 Jun 14; 470(6):909-921. PubMed ID: 29441404
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells.
    Kumerz M, Heiss EH, Schachner D, Atanasov AG, Dirsch VM.
    Mol Nutr Food Res; 2011 Aug 14; 55(8):1230-6. PubMed ID: 21732534
    [Abstract] [Full Text] [Related]

  • 7. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T.
    Mol Pharmacol; 2004 Apr 14; 65(4):832-41. PubMed ID: 15044612
    [Abstract] [Full Text] [Related]

  • 8. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
    ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Bäumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, Rosenkranz S.
    Cardiovasc Res; 2006 Jul 15; 71(2):331-41. PubMed ID: 16545786
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol inhibits glucose-induced migration of vascular smooth muscle cells mediated by focal adhesion kinase.
    Lin YC, Chen LH, Varadharajan T, Tsai MJ, Chia YC, Yuan TC, Sung PJ, Weng CF.
    Mol Nutr Food Res; 2014 Jul 15; 58(7):1389-401. PubMed ID: 24659233
    [Abstract] [Full Text] [Related]

  • 10. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    Mottola G, Chatterjee A, Wu B, Chen M, Conte MS.
    PLoS One; 2017 Jul 15; 12(3):e0174936. PubMed ID: 28362840
    [Abstract] [Full Text] [Related]

  • 11. Pyk2 inhibition promotes contractile differentiation in arterial smooth muscle.
    Grossi M, Bhattachariya A, Nordström I, Turczyńska KM, Svensson D, Albinsson S, Nilsson BO, Hellstrand P.
    J Cell Physiol; 2017 Nov 15; 232(11):3088-3102. PubMed ID: 28019664
    [Abstract] [Full Text] [Related]

  • 12. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.
    Planas-Rigol E, Terrades-Garcia N, Corbera-Bellalta M, Lozano E, Alba MA, Segarra M, Espígol-Frigolé G, Prieto-González S, Hernández-Rodríguez J, Preciado S, Lavilla R, Cid MC.
    Ann Rheum Dis; 2017 Sep 15; 76(9):1624-1634. PubMed ID: 28606962
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
    Revuelta-López E, Castellano J, Roura S, Gálvez-Montón C, Nasarre L, Benitez S, Bayes-Genis A, Badimon L, Llorente-Cortés V.
    Arterioscler Thromb Vasc Biol; 2013 Dec 15; 33(12):2877-87. PubMed ID: 24072693
    [Abstract] [Full Text] [Related]

  • 14. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
    Azar ZM, Mehdi MZ, Srivastava AK.
    Can J Physiol Pharmacol; 2006 Jul 15; 84(7):777-86. PubMed ID: 16998541
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.
    Xu W, Guo T, Zhang Y, Jiang X, Zhang Y, Zen K, Yu B, Zhang CY.
    Exp Cell Res; 2011 May 01; 317(8):1083-92. PubMed ID: 20955697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2.
    Hirata A, Igarashi M, Yamaguchi H, Suwabe A, Daimon M, Kato T, Tominaga M.
    Br J Pharmacol; 2000 Dec 01; 131(8):1521-30. PubMed ID: 11139427
    [Abstract] [Full Text] [Related]

  • 18. Vitisin B, a resveratrol tetramer, inhibits migration through inhibition of PDGF signaling and enhancement of cell adhesiveness in cultured vascular smooth muscle cells.
    Ong ET, Hwang TL, Huang YL, Lin CF, Wu WB.
    Toxicol Appl Pharmacol; 2011 Oct 15; 256(2):198-208. PubMed ID: 21871475
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.